| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.54 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |